Omicron booster vaccine transiently broadens memory B cell antibody response to SARS-CoV-2 variants
This study by Malek et al. evaluated the impact of a SARS-CoV-2 Omicron variant booster vaccine on the memory B cell (MBC) response. Using samples from the COVAIL vaccine trial, the researchers found that individuals who received a booster containing the Omicron variant experienced a transient increase in antibodies capable of binding both ancestral SARS-CoV-2 and the Omicron variant. The research addresses how vaccines may need to be updated to match evolving circulating strains of SARS-CoV-2 as the virus continues to evolve under immune pressure from vaccines and infections.
Key quotes
As SARS-CoV-2 continues to evolve in response to vaccine- and infection-induced immune pressure, vaccines will need to be updated to match currently circulating strains.
Individuals boosted with a vaccine containing the Omicron variant had a transient increase in antibodies that could bind both ancestral SARS-CoV-2 and the Omicron variant.
Evolving endemic viruses such as influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain major health threats.
From the article
You might also wanna read
Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 Patients
News Scan for Sep 02, 2020
SARS-CoV-2 RBD nanoparticle vaccine shows potent neutralization against variants in clinical studies
This article describes the characterization of a two-component protein nanoparticle vaccine platform (RBD-NP) that displays 60 copies of the

A critical review of mRNA vaccine safety and efficacy from mechanistic and public health perspectives
This article provides a critical review of mRNA vaccine safety and efficacy from mechanistic, preclinical, clinical, and public health persp

Emerging Evidence Challenges Immunity Debt Theory, Suggests SARS-CoV-2 Alters Immune Systems
Scientists are challenging the 'immunity debt' theory that explained post-pandemic infection surges, instead proposing that SARS-CoV-2 may b
Study Finds Routine Vaccines Linked to Over 50% Reduced Risk of Uveitis
A large-scale retrospective cohort study using electronic health records from multiple US health systems (2006-2025) found that routine vacc

Comments
Sign in to join the conversation.
No comments yet. Be the first.